Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment
2015 Standout
Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses
2012
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Fluid balance and acute kidney injury
2009
Acute kidney injury
2012 Standout
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function
2010
Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial
2008
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
2016 Standout
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery
2009
Clinical experience of hydroxyethyl starch (10% HES 200/0.5) in cerebral perfusion pressure protocol for severe head injury
2006
Colloid solutions for fluid resuscitation
2003
In vitro biological evaluation of high molecular weight hyperbranched polyglycerols
2007
Fluid Therapy and Surgical Outcomes in Elective Surgery: A Need for Reassessment in Fast-Track Surgery
2006
IgE and mast cells in allergic disease
2012 Standout
Severe Sepsis and Septic Shock
2013 Standout
Hydroxyethyl starches and dextran during hip replacement surgery: effects on blood volume and coagulation
2011 StandoutNobel
Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients
2008 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Acute kidney injury
2021 Standout
Comparison of the Plasma Volume-Expanding Effects of 6% Dextran 70, 5% Albumin, and 6% HES 130/0.4 After Hemorrhage in the Guinea Pig
2009
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
2010 Standout
In vivo biological evaluation of high molecular weight hyperbranched polyglycerols
2007
Perioperative fluid management in renal transplantation: a narrative review of the literature
2006
The influence of volume management on outcome
2007
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
2016 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Mechanisms of hydroxyethyl starch‐induced dilutional coagulopathy
2009
Parenteral fluid regimens for improving functional outcome in people with acute stroke
2015
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Anaphylaxis: Acute Treatment and Management
2010
Guidelines for the Primary Prevention of Stroke
2014 Standout
Colloid osmotic pressure and extravasation of plasma proteins following infusion of Ringer's acetate and hydroxyethyl starch 130/0.4
2015 StandoutNobel
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
2004 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Unimolecular Micelles based on Hydrophobically Derivatized Hyperbranched Polyglycerols: Biodistribution Studies
2008
Comparison of intermittent intratympanic steroid injection and near‐continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss
2013
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study
2012
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
2016 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Interactions between the volume effects of hydroxyethyl starch 130/0.4 and Ringer´s acetate
2013
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
Works of Frank Bepperling being referenced
The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment
2002
A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery
2000
Influence of a Long-Term, High-Dose Volume Therapy with 6% Hydroxyethyl Starch 130/0.4 or Crystalloid Solution on Hemodynamics, Rheology and Hemostasis in Patients with Acute Ischemic Stroke
2003
Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers
1998
Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats
2003
Hemodilution Therapy With Hydroxyethyl Starch Solution (130/0.4) in Unilateral Idiopathic Sudden Sensorineural Hearing Loss
2007
Hydroxyethyl Starch (HES) [130/0.4],??? a New HES Specification
2003
Volume Efficacy and Reduced Influence on Measures of Coagulation Using Hydroxyethyl Starch 130/0.4 (6%) with an Optimised in???Vivo???Molecular Weight in Orthopaedic Surgery
2004
Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution †
2003
The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment
2002
Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients.
2012
Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers
1999
Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study
2001